| Sri Valli Chekuri, | |
|
16351 Rotunda Dr, Dearborn, MI 48120-1170 | |
| (734) 718-2947 | |
| Not Available |
| Full Name | Sri Valli Chekuri |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 16351 Rotunda Dr, Dearborn, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124730247 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5501302338 (Michigan) | Primary |
| Provider Name | Therapy Management Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407293640 PECOS PAC ID: 2961630645 Enrollment ID: O20140103000154 |
News Archive
DePuy Synthes Trauma announces that it is launching the new Radial Head Prosthesis System for primary and revision joint replacement of the radial head to restore joint function. The System offers several benefits over current technologies.
Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.
› Verified 8 days ago
| Provider Name | Tmi East Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336709252 PECOS PAC ID: 3274864665 Enrollment ID: O20200420003011 |
News Archive
DePuy Synthes Trauma announces that it is launching the new Radial Head Prosthesis System for primary and revision joint replacement of the radial head to restore joint function. The System offers several benefits over current technologies.
Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sri Valli Chekuri, 851 Penniman Ave, Plymouth, MI 48170-1621 Ph: (248) 349-9595 | Sri Valli Chekuri, 16351 Rotunda Dr, Dearborn, MI 48120-1170 Ph: (734) 718-2947 |
News Archive
DePuy Synthes Trauma announces that it is launching the new Radial Head Prosthesis System for primary and revision joint replacement of the radial head to restore joint function. The System offers several benefits over current technologies.
Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.
› Verified 8 days ago
Healthwise Physical Therapy Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5445 Oakman Blvd, Dearborn, MI 48126 Phone: 313-584-4625 Fax: 313-584-4628 | |
Dr. Zarine Minwalla, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 20251 Carlysle St, Dearborn, MI 48124 Phone: 313-278-4601 | |
Sara Michelle Ryder, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 23852 Michigan Ave, Dearborn, MI 48124 Phone: 313-565-4222 Fax: 313-565-8703 | |
Anu Thomas, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 21031 Michigan Ave Ste C, Dearborn, MI 48124 Phone: 313-565-2224 | |
Muhammad Amin Anjum, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5445 Oakman Blvd, Dearborn, MI 48126 Phone: 313-581-7971 Fax: 313-581-8028 | |
Patricia Stefanek, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7760 | |
Mrs. Kevy Elizabeth Nycek, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 18501 Rotunda Dr Ste 200, Dearborn, MI 48124 Phone: 313-996-1928 |